XT
NMRA icon

XTX Topco’s Neumora Therapeutics NMRA Stock Holding History

XTX Topco’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$433K Buy
221,848
+107,935
+95% +$280K 0.01% 2173
2025
Q4 		$204K Buy
+113,913
New +$249K 0.01% 2388
2025
Q2 		– Sell
-233,597
Closed -$234K – 2905
2025
Q1 		$234K Buy
233,597
+211,759
+970% +$363K 0.01% 1590
2024
Q4 		$231K Buy
+21,838
New +$262K 0.02% 1440
2024
Q2 		– Sell
-12,352
Closed -$170K – 2279
2024
Q1 		$170K Buy
+12,352
New +$200K 0.02% 1226

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return

XTX Topco's NMRA Position: Q1 2026 in Review

XTX Topco increased its Neumora Therapeutics (NMRA) stake by 95% in Q1 2026, buying an estimated $280K and bringing the position to 221,848 shares worth $433K. The position accounts for 0.01% of the portfolio, ranked #2173.

XTX Topco first reported a position in NMRA in Q1 2024 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold NMRA as of Q1 2026.

  • XTX Topco held 221,848 shares of Neumora Therapeutics worth $433K as of Q1 2026.
  • XTX Topco bought 107,935 Neumora Therapeutics shares in Q1 2026, an estimated $280K.
  • Neumora Therapeutics made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2173 holding.
  • XTX Topco first reported a position in Neumora Therapeutics in Q1 2024 and has held it in 5 quarters since.
  • 114 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.